Aeon
Connecting Sign in

Insider trades appear within seconds, the rest within the hour.

Get alerts

← Feed

APRENasdaq

Aprea Therapeutics, Inc.

Alert me on APRE
0
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

Six months

APRE stock chart by TradingView

After each filing

4
Feb 3 Buy Hamill John P. Insider
1 week
−4.9%S&P +0.4%
1 month
+36.9%S&P −1.2%
3 months
+25.2%S&P +5.3%
6 months
−7.8%S&P +12.2%
Feb 3 Buy Gilad Oren Insider
1 week
−4.9%S&P +0.4%
1 month
+36.9%S&P −1.2%
3 months
+25.2%S&P +5.3%
6 months
−7.8%S&P +12.2%
Dec 11, 2025 Buy Duey Marc Insider
1 week
−3.7%S&P −1.8%
1 month
−4.5%S&P +1.0%
3 months
−20.0%S&P −2.6%
6 months
−26.1%S&P +10.2%
Dec 11, 2025 Buy Hamill John P. Insider
1 week
−3.7%S&P −1.8%
1 month
−4.5%S&P +1.0%
3 months
−20.0%S&P −2.6%
6 months
−26.1%S&P +10.2%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for APRE

26 held · newest 526 held · newest 2
Loading the filings.
See all 26 filings for APRE

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
No lobbying reports on file.